This HTML5 document contains 122 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://dx.doi.org/10.1038/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q39006531
rdf:type
wikibase:Item
schema:description
tudományos cikk научная статья 2015年论文 articolo scientifico 2015年论文 ১৫ মে ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vedecký článok tieteellinen artikkeli article scientifique სამეცნიერო სტატია научни чланак naučni članak vitenskapelig artikkel artigo científico scienca artikolo 2015年论文 2015年论文 artigo científico 2015年論文 bilimsel makale bài báo khoa học articol științific 2015년 논문 2015年論文 artikull shkencor scientific article published on 15 May 2015 vědecký článek vitskapeleg artikkel επιστημονικό άρθρο научни чланак מאמר מדעי мақолаи илмӣ article científic artykuł naukowy wissenschaftlicher Artikel artigo científico научна статия 2015年论文 videnskabelig artikel 2015年論文 scientific article published on 15 May 2015 vetenskaplig artikel wetenschappelijk artikel 2015年論文 مقالة علمية نشرت في 15 مايو 2015 artikel ilmiah 2015年論文 2015年の論文 artikulong pang-agham article scientific 2015 nî lūn-bûn บทความทางวิทยาศาสตร์ scientific article published on 15 May 2015 teaduslik artikkel 2015年论文 artículo científico publicado en 2015 наукова стаття, опублікована в травні 2015 artículu científicu espublizáu en 2015
p:P577
wds:Q39006531-78CEBE3E-B137-4349-844E-A022FB681246
wdt:P577
2015-05-15T00:00:00Z
p:P2888
wds:Q39006531-5B1D247D-4971-4063-9736-DD5907474C9E
wdt:P2888
n8:eye.2015.80
p:P2860
wds:Q39006531-B3C48AD2-FA58-4221-9610-F584B7572ACB wds:Q39006531-BEDEAB2F-BFE3-4BA9-887B-13C877864866 wds:Q39006531-CE74F0FC-D87B-4490-A9EC-E88CDA28C0AC wds:Q39006531-8451333E-3429-42F9-BCAE-4473E328FCAE wds:Q39006531-986FD93D-8B41-4EDF-9FD6-4495C12A3441 wds:Q39006531-5D7695EE-A435-46B9-887C-22F2D2CF3108 wds:Q39006531-4D062530-F372-42D6-A9AC-6DCD68D352B1 wds:Q39006531-4F857020-3BB5-4295-B3C5-5B7DF6377520 wds:Q39006531-5584D5E0-4BDA-400E-A38E-06B751C7E399 wds:Q39006531-02AE3E02-5ECF-42AD-9CBB-D9E8D149B530
wdt:P2860
wd:Q52529779 wd:Q35449309 wd:Q38109457 wd:Q85160758 wd:Q33246808 wd:Q36019410 wd:Q30582809 wd:Q34045620 wd:Q85794598 wd:Q36053957
p:P2093
wds:Q39006531-D9720482-586E-48AA-8A1A-E069574CEF24 wds:Q39006531-E309B013-C2F2-44D5-BE32-63F812092018 wds:Q39006531-8FD0D8F6-D46D-42D9-AA7C-3DDE8724EA2D
wdt:P2093
D Sarraf L Kuehlewein S R Sadda
rdfs:label
OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy
skos:prefLabel
OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy
schema:name
OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy
p:P1476
wds:Q39006531-459723F6-CEE6-4696-B761-B3EBEB7E2782
wdt:P1476
OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy
p:P304
wds:Q39006531-F1E1B7C4-F7FE-48B2-BC1C-AC5BB561D22E
wdt:P304
932-935
p:P31
wds:Q39006531-EF84C7AC-05AA-4597-BF1A-FD72F2379345
wdt:P31
wd:Q13442814
p:P921
wds:Q39006531-E3E8BF0B-62B7-4228-AFCA-0887524A0C56 wds:Q39006531-171AA694-B8ED-42C6-8D5A-697B79FDFFD3
wdt:P921
wd:Q468414 wd:Q1281049
p:P698
wds:Q39006531-9B23CB03-D7C0-4A8B-9A14-39A42C7D1914
wdtn:P698
n12:25976641
wdt:P698
25976641
p:P1433
wds:Q39006531-71C49C1C-7E75-4FE6-9413-945F53909874
wdt:P1433
wd:Q10278937
p:P433
wds:Q39006531-06E20B21-205B-49FA-9A81-5B733182B850
p:P478
wds:Q39006531-0D8BC1AC-06B9-4C71-BA90-0D9FE5FB1A45
wdt:P433
7
wdt:P478
29
p:P356
wds:Q39006531-61184120-E38F-4121-B201-C6446A181F09
wdtn:P356
n13:EYE.2015.80
wdt:P356
10.1038/EYE.2015.80
p:P932
wds:Q39006531-081ECE13-7F7F-4EEC-A8BF-877989AEFC1B
wdt:P932
4506353